Hyperthermia is a cancer treatment modality in which tumour tissue is heated to temperatures of 39–43°C to enhance the effectiveness of radiotherapy and chemotherapy. At these temperatures, hyperthermia acts as a potent radio- and chemosensitiser — inhibiting DNA repair, improving tissue blood flow and oxygenation, and increasing vessel permeability, making tumour cells significantly more vulnerable to radiation and systemic therapies.
Superficial hyperthermia combined with radiotherapy is included in leading international breast cancer treatment guidelines, including DEGRO, AGO and the German S3 guidelines, and is cited as an approved method in the Quality Assurance Guidelines for Superficial Hyperthermia Clinical Trials issued by the European Society for Hyperthermic Oncology (ESHO).
The hydrosun® TWH1500
RMS Medical Supplies is the authorised UK distributor for the hydrosun® TWH1500 — the world’s first device for effective contact-free superficial hyperthermia, developed and manufactured by Hydrosun Medizintechnik GmbH, Müllheim, Germany, in partnership with heckel medizintechnik gmbh, a pioneer in the field of hyperthermia.
The TWH1500 uses Water-filtered Infrared A (wIRA) technology to deliver a high and compliant energy input to deeper tissue layers — achieving an effective heating depth of at least 20mm (>39°C) with maximum skin temperature set at 42–43°C, while reducing the incidence of thermal skin damage (TSD) to almost 0%. A computer-controlled feedback system registers the detailed temperature distribution of the treated skin area in real time, providing automatic on/off control within a defined maximum temperature range with all treatment data documented and stored.
Key Features
Contact-free energy delivery — no body fixation or painful applicator contact, including with ulcerated lesions
Continuous real-time thermographic control with automatic switch on/off functions
Twin-applicator system covering large treatment areas regardless of heterogenous body contours
Effective heating depth of at least 20mm (>39°C) with maximum skin temperature set at 42–43°C
Acute thermal skin damage reduced to almost 0%
Compatible with metal implants and pacemakers — no shielding required
Real-time physiological monitoring during and after treatment
TWH1500 system diagram showing wIRA radiators, thermography units, safety alarm pyrometers and therapy control unit
About Heckel/Hydrosun
The hydrosun® TWH1500 is developed and manufactured by Hydrosun Medizintechnik GmbH — a pioneer and world market leader in water-filtered infrared-A technology, certified to ISO 13485 and MDD 93/42/EEC, Annex II, and CE marked (0123, TÜV SÜD). Heckel medizintechnik gmbh, a strategic partner of Hydrosun, is the exclusive global distributor for the TWH1500 and the Heckel-HT3000 whole-body hyperthermia device.
RMS Medical Supplies is proud to represent Heckel/Hydrosun as the authorised UK distributor for the hydrosun® TWH1500.
Resources and Further Reading
The following resources provide further information about the hydrosun® TWH1500 and the clinical evidence base for wIRA superficial hyperthermia:
For comprehensive information surrounding publications as well as ongoing clinical trials, please visit the Science Page of the Heckel website
Visit Heckel/Hydrosun
For more information about the manufacturer and the full range of hyperthermia solutions, as well as for comprehensive information surrounding the scientific evidence, including publications and ongoing trials, visit the Heckel website.
To request further information about the hydrosun® TWH1500, to discuss NICE guidelines, or to discuss your facility’s requirements, please contact our team.
Ready to discuss your project?
Our team of engineers and specialists are here to help with installation, servicing, and product selection.
